ESG

Fraud losses are soaring as AI-powered scams get smarter. A new wave of defensive AI is fighting back to protect your digital life from deepfakes and fraud.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

With cash dwindling and no FDA approval, ENDRA is exploring a sale. Will its innovative TAEUS® liver scanner find a champion or fade into obscurity?

A new study reveals Kansas City University's $498.9M annual economic impact, fueling jobs and tackling critical physician shortages across the Midwest.

SWBC's move to INTX's modern platform signals a major industry trend, replacing outdated systems to boost efficiency, governance, and scalability.

A unique partnership between a debt acquirer and a top charity is pushing for major UK financial inclusion reform from within the House of Lords.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.

With €10M in new funding, Berlin-based Cellbricks is moving its biofabricated human tissues from lab to preclinical trials, promising a new era for patients.

Following a 40-year career shaping biotech finance, Jessica Chutter's move to PTC's board signals major strategic ambitions for the rare disease firm.

Bunzl Canada has appointed the world's first in-house cleaning verification experts, a move set to redefine sustainability and compliance in the industry.

A new NIH-funded study reveals that while Medicare covers acupuncture for back pain, federal rules create vast "care deserts" for seniors seeking relief.

Swedish biotech VERIGRAFT begins a pivotal trial for a personalized, lab-grown vein, offering hope for a true cure for millions with chronic venous insufficiency.

From the heart of Arabia, AlUla Peregrina brings a patented active to the global stage, promising scientifically-backed, ethical longevity beauty.

Firms invest heavily in fleet tech, yet equipment sits idle 50% of the time. A new report reveals a costly gap between digital adoption and real-world use.

With grid connection queues stalling AI growth, a new strategy prioritizes CPU efficiency over raw power, reshaping the UK's tech infrastructure.

LGT Wealth Management UK partners with AI platform Addepar, signaling a major tech upgrade to personalize service for the modern, complex investor.

As funding expires for Wayne State's 35-year heart experiments on dogs, advocates and lawmakers urge the NIH to end a legacy of waste and suffering.

Chinese innovator HyperLeap debuts its modular sorting robots in Europe, promising to solve labor shortages and space constraints in a strained industry.

A 50% surge in surrogate insurance demand signals India's new regulated era, but experts warn that inadequate coverage leaves surrogate mothers at grave risk.

With new patents for water quality analysis and precision flow, LeakSecure® moves beyond leak detection to offer homeowners unprecedented proactive insights.